Autoinflammatory & rare systemic diseases

Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort

Joint Bone SpinePublished Cohort study

Authors' conclusion

Obese patients at the time of diagnosis of the disease were characterised by a lower prevalence of sore throat, serositis, as well as by higher values of CRP and ferritin. Obesity was also a predictive factor for a chronic disease course and bDMARD failure

Study context

Population
Adult-onset Still's disease (AOSD) patients with body mass index (BMI) registered in the multicentre GIRRCS cohort (Italy)BMI registered
Participants
139 patients
Exposure
Obese vs non-obese AOSD patients
  • Obesen = 26
Outcome
Clinical features and outcomes of obese vs non-obese AOSD
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

Obese

18.7%

26

Lower rate of sore throat in obese patients
P < 0.05
Lower rate of pericarditis in obese patients
P < 0.05
Lower rate of pleuritis in obese patients
P < 0.05
Higher C-reactive protein (CRP) in obese patients
P < 0.05
Higher ferritin in obese patients
P < 0.05
Biologic disease-modifying antirheumatic drug (bDMARD) failure in subsequent follow-up in obese patients
P < 0.05
Higher rate of comorbidity in obese vs non-obese patients
P < 0.05

Observational data: associations, not effects.

Further findings

Chronic disease course (obesity as predictor)

HR (95% CI)P value
ObesityUnivariate analysis1.72 (1.03–2.51)P < 0.05
ObesityMultivariate analysis1.85 (1.45–2.89)P < 0.05

bDMARD failure (obesity as predictor)

HR (95% CI)P value
ObesityUnivariate analysis3.03 (1.42–6.45)P < 0.01
ObesityMultivariate analysis3.59 (1.55–8.27)P < 0.01

Original publication

Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort. Joint Bone Spine. Published 18 April 2023. doi:10.1016/j.jbspin.2023.105576

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.